John Sharp
Overview
Explore the profile of John Sharp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
987
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greib A, Zhao S, Ploch M, Henricks J, Easterling R, Moodabagil M, et al.
Oncoimmunology
. 2025 Feb;
14(1):2469375.
PMID: 39981683
Immune checkpoint inhibitors (ICIs) are first line treatment for advanced lung cancer. Tobacco use is a shared risk factor for lung cancer and chronic obstructive pulmonary disease (COPD). Although many...
2.
Nassar A, Kim S, Aredo J, Feng J, Shepherd F, Xu C, et al.
J Thorac Oncol
. 2024 Jan;
19(6):928-940.
PMID: 38278303
Introduction: Durvalumab improves survival when used as consolidation therapy after chemoradiation (CRT) in patients with stage III NSCLC. The optimal consolidation therapy for patients with EGFR-mutant (EGFRmut) stage III NSCLC...
3.
Cheng K, Tint N, Sharp J, Alexander P
J Cataract Refract Surg
. 2022 Nov;
48(12):1453-1461.
PMID: 36449676
Despite the safety and efficacy of cataract surgery, intraoperative complications can hamper the ability to place an intraocular lens in the capsular bag. With vast numbers of cataract surgeries performed...
4.
Sharp J, Chuang K
Fed Pract
. 2022 Nov;
39(6):281-285.
PMID: 36404938
Background: Pneumatosis intestinalis is the presence of gas within the walls of the intestine on imaging and has variable clinical significance, ranging from an incidental finding to a harbinger of...
5.
Sharp J, Prasad V
BMC Cancer
. 2022 Jan;
22(1):70.
PMID: 35034621
Importance: It is unknown whether and to what degree trials submitted to the US FDA to support drug approval adhere to NCCN guideline-recommended care in their baseline and surveillance CNS...
6.
Sharp J, Khaki A, Prasad V
JAMA Netw Open
. 2021 Sep;
4(9):e2124728.
PMID: 34570209
Importance: Immunotherapy (anti-programmed death ligand 1 antibodies) is associated with improved survival rates in advanced kidney cell carcinoma (KCC) after progression on first-line tyrosine kinase inhibitor (TKI) treatment. It is...
7.
Henderson P, Quasim T, Asher A, Campbell L, Daniel M, Davey L, et al.
J Rehabil Med
. 2021 Apr;
53(6):jrm00206.
PMID: 33856038
Objectives: To describe the long-term outcomes of cardiac intensive care unit patients and their primary caregivers, and to explore the feasibility of implementing a complex intervention, designed to support problems...
8.
Vitish-Sharma P, King A, Stead R, Sharp J, Abbas A, Guo B, et al.
JMIR Perioper Med
. 2021 Jan;
1(2):e11221.
PMID: 33401368
Background: The incidence of perioperative visual loss following colorectal surgery in the US is quoted as 1.24 per 10,000. Raised intraocular pressure (IOP) during extreme Trendelenburg position leading to reduced...
9.
Makhni S, Atreja A, Sheon A, Van Winkle B, Sharp J, Carpenter N
Digit Biomark
. 2020 Feb;
1(1):64-72.
PMID: 32095746
Background: The Network of Digital Evidence (NODE) was formed to further advance the field of health information technology (HIT) and evidence-based digital medicine at different healthcare institutions nationwide. As the...
10.
Thomson D, Maddison A, Sharp J
J Cardiopulm Rehabil Prev
. 2019 Jun;
39(4):253-258.
PMID: 31241518
Background: Social rehabilitation, including return to work (RTW), is a key indicator of transplant success. However, little is known regarding the RTW rate following heart transplantation or the factors influencing...